Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.51 |
| ▸ | TLR7 | Q9NYK1 | 10/20 | 0.51 |
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | DHFR | P00374 | 1/20 | 0.43 |
| ▸ | APP | P05067 | 1/20 | 0.43 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL853209 | 0.88 | DHFR (0.59) | TLR7TLR8DHFRADORA3ADORA2A | |
| SCHEMBL855086 | 0.87 | DHFR (0.47) | TLR7TLR8DHFR | |
| SCHEMBL853346 | 0.86 | TLR7 (0.47) | TLR7TLR8DHFRSLC2A1 | |
| SCHEMBL853783 | 0.85 | TLR7 (0.45) | TLR7TLR8DHFR | |
| SCHEMBL854804 | 0.84 | TLR7 (0.55) | TLR7TLR8DHFR | |
| SCHEMBL853213 | 0.84 | TLR7 (0.57) | TLR7TLR8DHFR | |
| SCHEMBL3699453 | 0.81 | TLR7 (0.74) | TLR7TLR8NPSR1 | |
| SCHEMBL853935 | 0.81 | TLR7 (0.51) | TLR7TLR8 | |
| SCHEMBL861355 | 0.81 | TLR7 (0.56) | TLR7TLR8 | |
| SCHEMBL853436 | 0.81 | TLR7 (0.54) | TLR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2432768-A1 | NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND FURTHER DISEASES | AstraZeneca AB (SE) | 2012-03-28 | — | — | EP | disclosed |
| WO-2010133885-A1 | NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND FURTHER DISEASES | ASTRAZENECA AB (SE) | 2010-11-25 | — | — | WO | disclosed |